Bryan D. Choi

6.5k total citations · 3 hit papers
105 papers, 4.2k citations indexed

About

Bryan D. Choi is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Bryan D. Choi has authored 105 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 36 papers in Immunology and 31 papers in Genetics. Recurrent topics in Bryan D. Choi's work include CAR-T cell therapy research (47 papers), Glioma Diagnosis and Treatment (31 papers) and Immunotherapy and Immune Responses (21 papers). Bryan D. Choi is often cited by papers focused on CAR-T cell therapy research (47 papers), Glioma Diagnosis and Treatment (31 papers) and Immunotherapy and Immune Responses (21 papers). Bryan D. Choi collaborates with scholars based in United States, Germany and Japan. Bryan D. Choi's co-authors include Brad Spellberg, J. Perlroth, John H. Sampson, Marcela V. Maus, Darell D. Bigner, William T. Curry, Luis Sánchez-Pérez, Matthew J. Frigault, Mark B. Leick and Patrick C. Gedeon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Bryan D. Choi

98 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nosocomial fungal infections: epidemiology, diagnosis, and treatment

2007 565 citations Bryan D. Choi et al. profile →
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

2019 426 citations Bryan D. Choi, Xiaoling Yu et al. Nature Biotechnology profile →
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

2024 210 citations Bryan D. Choi, Matthew J. Frigault et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan D. Choi United States	29	2.5k	1.2k	1.1k	884	689	105	4.2k
Ulrike Koehl Germany	45	2.9k 1.1×	3.0k 2.4×	1.3k 1.2×	379 0.4×	423 0.6×	155	5.6k
Omkar U. Kawalekar United States	13	3.1k 1.2×	1.8k 1.4×	1.3k 1.2×	1.1k 1.3×	126 0.2×	20	4.5k
Vijay Bhoj United States	17	2.0k 0.8×	1.3k 1.1×	916 0.9×	521 0.6×	163 0.2×	39	3.4k
Elizabeth A. Reap United States	27	1.2k 0.5×	2.8k 2.3×	1.2k 1.1×	309 0.3×	510 0.7×	62	4.4k
Reno Debets Netherlands	44	4.1k 1.6×	3.1k 2.5×	1.7k 1.6×	782 0.9×	195 0.3×	161	6.2k
Pedro Berraondo Spain	36	2.9k 1.1×	3.3k 2.6×	1.8k 1.7×	463 0.5×	370 0.5×	164	5.9k
Chrystal M. Paulos United States	39	5.4k 2.1×	5.5k 4.4×	2.3k 2.2×	795 0.9×	195 0.3×	132	9.2k
Tuna Mutis Netherlands	50	4.1k 1.6×	4.7k 3.8×	2.7k 2.6×	367 0.4×	822 1.2×	180	9.4k
Richard P. Junghans United States	41	2.4k 0.9×	2.4k 1.9×	2.0k 1.8×	559 0.6×	209 0.3×	99	5.7k
Adrian Bot United States	35	2.2k 0.9×	2.0k 1.6×	1.1k 1.0×	548 0.6×	70 0.1×	132	4.3k

Countries citing papers authored by Bryan D. Choi

Since Specialization

Citations

This map shows the geographic impact of Bryan D. Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan D. Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan D. Choi more than expected).

Fields of papers citing papers by Bryan D. Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan D. Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan D. Choi. The network helps show where Bryan D. Choi may publish in the future.

Co-authorship network of co-authors of Bryan D. Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan D. Choi. A scholar is included among the top collaborators of Bryan D. Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan D. Choi. Bryan D. Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jason, Florian Geßler, Omar Arnaout, et al.. (2025). Translational advancements in tumor vaccine therapies for glioblastomas. Neuro-Oncology Advances. 7(Supplement_4). iv72–iv83.

Nia, Hadi T., Meenal Datta, Ashwin S. Kumar, et al.. (2025). Solid Stress Estimations via Intraoperative 3D Navigation in Patients with Brain Tumors. Clinical Cancer Research. 31(16). 3571–3580. 1 indexed citations

Shankar, Ganesh M., et al.. (2025). Quantity versus quality: analysis of research publications in the 2023 neurosurgery match. Journal of neurosurgery. 142(6). 1818–1825. 1 indexed citations

Ramapriyan, Rishab, et al.. (2024). Pre-Clinical Models for CAR T-Cell Therapy for Glioma. Cells. 13(17). 1480–1480. 3 indexed citations

Ramapriyan, Rishab, María Martínez-Lage, Julie J. Miller, et al.. (2024). Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma. Clinical Cancer Research. 30(18). 4068–4076. 4 indexed citations

Nanda, Pranav, Faith C. Robertson, Mercy H. Mazurek, et al.. (2024). Sub-Internship Academy: Implementation and Evaluation of Single-Day Resident-Driven Focused Sub-Internship Preparation Course. World Neurosurgery. 193. 533–542.

Mazurek, Mercy H., et al.. (2024). Navigated Intraoperative Ultrasound Offers Effective and Efficient Real-Time Analysis of Intracranial Tumor Resection and Brain Shift. Operative Neurosurgery. 28(2). 148–158. 3 indexed citations

Park, Sangwoo, Marcela V. Maus, & Bryan D. Choi. (2024). CAR-T cell therapy for the treatment of adult high-grade gliomas. npj Precision Oncology. 8(1). 279–279. 17 indexed citations

Choi, Bryan D., et al.. (2021). Surgical advances in the management of brain metastases. Neuro-Oncology Advances. 3(Supplement_5). v4–v15. 15 indexed citations

10.

Kfoury, Youmna, Ninib Baryawno, Nicolas Sévère, et al.. (2021). Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell. 39(11). 1464–1478.e8. 148 indexed citations

11.

Lewis, Nuruddeen D., Chang Ling Sia, Katherine Kirwin, et al.. (2020). Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12. Molecular Cancer Therapeutics. 20(3). 523–534. 79 indexed citations

12.

Schmidts, Andrea, Amanda A. Bouffard, Angela C. Boroughs, et al.. (2020). Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources. Journal for ImmunoTherapy of Cancer. 8(2). e000990–e000990. 18 indexed citations

13.

Frigault, Matthew J., Jörg Dietrich, María Martínez-Lage, et al.. (2019). Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma. Blood. 134(11). 860–866. 160 indexed citations

14.

Schmidts, Andrea, Maria Ormhøj, Bryan D. Choi, et al.. (2019). Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Advances. 3(21). 3248–3260. 85 indexed citations

15.

Choi, Bryan D., Xiaoling Yu, Ana P. Castaño, et al.. (2019). CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nature Biotechnology. 37(9). 1049–1058. 426 indexed citations breakdown →

16.

Gedeon, Patrick C., Teilo Schaller, Satish K. Chitneni, et al.. (2018). A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. Clinical Cancer Research. 24(15). 3611–3631. 38 indexed citations

17.

Schmidts, Andrea, Maria Ormhøj, Allison Taylor, et al.. (2018). Engineering an Optimized Trimeric APRIL-Based CAR to Broaden Targetability of Multiple Myeloma. Blood. 132(Supplement 1). 2059–2059. 6 indexed citations

18.

Choi, Bryan D., Katie Fehnel, & William E. Butler. (2017). Rare Giant Prevertebral Thoracic Myelomeningocele. World Neurosurgery. 109. 296–297. 1 indexed citations

19.

Sampson, John H., Bryan D. Choi, Luis Sánchez-Pérez, et al.. (2013). EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss. Clinical Cancer Research. 20(4). 972–984. 241 indexed citations

20.

Reitman, Zachary J., Bryan D. Choi, Ivan Spasojević, et al.. (2012). Enzyme redesign guided by cancer-derived IDH1 mutations. Nature Chemical Biology. 8(11). 887–889. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact